27th May 2025 Plain language summary: Five-year results of nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer
19th May 2022 Plain language summary of results from the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancer
